Oneness Biotech Valuation

Is ONEA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ONEA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ONEA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ONEA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ONEA?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for ONEA. This is calculated by dividing ONEA's market cap by their current preferred multiple.
What is ONEA's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	NT$67.04b

ONEA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	592.4x
Enterprise Value/EBITDA	-88.2x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does ONEA's PB Ratio compare to its peers?

The above table shows the PB ratio for ONEA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	1.6x
603858 Shandong Buchang Pharmaceuticals	1.5x	n/a	CN¥17.5b
600867 Tonghua Dongbao Pharmaceutical	2.4x	54.3%	CN¥15.4b
600216 Zhejiang Medicine	1.5x	27.0%	CN¥14.8b
600420 Shanghai Shyndec Pharmaceutical	1.2x	13.8%	CN¥15.4b
ONEA Oneness Biotech	5x	11.4%	US$67.0b

Price-To-Book vs Peers: ONEA is expensive based on its Price-To-Book Ratio (5x) compared to the peer average (1.6x).

Price to Earnings Ratio vs Industry

How does ONEA's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	0%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	0%
	n/a	n/a	n/a

No more companies

Price-To-Book vs Industry: ONEA is expensive based on its Price-To-Book Ratio (5x) compared to the European Pharmaceuticals industry average (2.4x).

Price to Book Ratio vs Fair Ratio

What is ONEA's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ONEA PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	5x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate ONEA's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.